z-logo
Premium
Reshaping the therapeutic landscape of chronic lymphocytic leukaemia in the era of targeted therapy
Author(s) -
Mondello Patrizia,
Zelenetz Andrew D.
Publication year - 2020
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.17031
Subject(s) - bendamustine , ibrutinib , ighv@ , chlorambucil , fludarabine , medicine , rituximab , chronic lymphocytic leukemia , oncology , bruton's tyrosine kinase , venetoclax , progression free survival , alemtuzumab , obinutuzumab , cyclophosphamide , leukemia , transplantation , chemotherapy , lymphoma , tyrosine kinase , receptor

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom